Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;26(5):180.
doi: 10.1007/s10856-015-5520-5. Epub 2015 Apr 17.

3D functional and perfusable microvascular networks for organotypic microfluidic models

Affiliations
Review

3D functional and perfusable microvascular networks for organotypic microfluidic models

Simone Bersini et al. J Mater Sci Mater Med. 2015 May.

Abstract

The metastatic dissemination of cancer cells from primary tumors to secondary loci is a complex and multistep process including local invasion, intravasation, survival in the blood stream and extravasation towards the metastatic site. It is well known cancer metastases follow organ-specific pathways with selected primary tumors mainly metastasizing towards a specific panel of secondary organs (Steven Paget's theory 1889). However, circulatory patterns and microarchitecture of capillary networks play a key role in the metastatic spread as well (James Ewing's theory 1929). Taking into account both these factors would be critical to develop more complex and physiologically relevant in vitro cancer models. This review presents recent advances in the generation of microvascularized systems through microfluidic approaches and discusses promising results achieved by organ-on-a-chip platforms mimicking the pathophysiology of the functional units of specific organs. The combination of physiologically-like microvascular networks and organotypic microenvironments would foster a new generation of in vitro cancer models to more effectively screen new therapeutics, design personalized medicine treatments and investigate molecular pathways involved in cancer metastases.

PubMed Disclaimer

References

    1. Nat Rev Cancer. 2009 Apr;9(4):239-52 - PubMed
    1. Nat Rev Cancer. 2013 Dec;13(12):858-70 - PubMed
    1. J Cell Biol. 2004 Oct 25;167(2):223-9 - PubMed
    1. Am J Pathol. 2005 Sep;167(3):749-59 - PubMed
    1. Science. 2011 Mar 25;331(6024):1559-64 - PubMed

Publication types

MeSH terms

LinkOut - more resources